Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1398646 | European Journal of Medicinal Chemistry | 2016 | 12 Pages |
•We have found a novel scaffold with better potency as antitumor agents.•Target compound 35 could arrest G0/G1 cell-cycle and induce apoptosis of SW620 cells in a dose-dependent manner.•35 blocked MCF-7 cancer cell migration with low toxicity to normal LO2 cells.•35 inhibited tumor growth by 52.96% at 80 mg/kg/48 h for 20 days.
In this study, a series of novel molecules containing chromeno [3,4-d] imidazol-4(1H)-one was synthesized and their biological activities were evaluated. Among them, compound 35 showed a dramatic anticancer activity against HCT116 and MCF-7, and the flow cytometry assays demonstrated that it could arrest G0/G1 cell-cycle and induce apoptosis of SW620 cells in a dose-dependent manner. Besides, it also blocked MCF-7 cancer cell migration. Moreover, it inhibited tumor growth in HCT116 subcutaneously implanted xenografted mice. Taken together, compound 35 may be a promising candidate for anti-cancer agent as well as metastatic one.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide